COMPARE · Data as of August 24, 2026

DOCS vs HNGE

Verdict: Side-by-side breakdown using the Bull Rankings model. DOCS scored 84.2, HNGE scored 72.0 — DOCS leads.
Compare another set
DOCS
Doximity, Inc.
Health Information Services · Quality-Growth
84.2
$25.30 · $4.5B
fundamentals as of
Score gap
12.2
DOCS leads
HNGE
Hinge Health, Inc.
Health Information Services · Quality-Growth
72
$89.98 · $7.3B
fundamentals as of
  • CheapestHNGE10.9x
  • Fastest growthHNGE+49.8%
  • Strongest balance sheetDOCS0.01
  • Highest qualityHNGE97 / 100
  • Largest discount to fair valueDOCS-9%
THE BULL RANKINGS SCORECARD84.2/ 100 · BULL SCOREPEER MEDIANQUALITY88.6GROWTH85.0VALUE79.3
THE BULL RANKINGS SCORECARD72.0/ 100 · BULL SCOREPEER MEDIANQUALITY96.5GROWTH66.3VALUE70.0
DOCSHNGEQuality88.696.5Growth85.066.3Value79.370.0
cheap & fastrevenue growth →← cheaper (lower multiple)1%60%5.9x35xDOCSHNGE

Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.

FCFDOCS$306mHNGE$290m
RevDOCS+11.2%HNGE+49.8%
D/EDOCS0.01HNGE0.02
P/EDOCS30.1xHNGE10.9x
PEGDOCS0.59HNGE0.38
DOCS
stronger →← stronger
HNGE
89
Qualityreturns · margins · balance sheet
97
85
Growthrevenue & earnings expansion
66
79
Valuevaluation vs sector peers
70
DOCS is stronger on 2 of 3 pillars.
DOCS
HNGE
$306mC
FCF
$290mC
+11.2%B
Rev
+49.8%A
0.01A-
D/E
0.02A-
30.1xB
P/E
10.9xA
0.59A-
PEG
0.38A
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
DOCS
HNGE
9% below
Price vs fair valuelower is cheaper
7% above
~7%/yr
Growth the price implies10-yr FCF · lower = less priced in
~16%/yr
-5%
1-yr DCF upside
-29%
+10%
5-yr DCF upside
-6%
+35%
10-yr DCF upside
+40%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
DOCS
Why this score
  • Durable high returns
HNGE
Why this score
  • Short track record
DOCSDoximity, Inc.
Health Information Services · $25.30 · beta 1.21
Why now
Health Information Services · market cap $4.5b. Down 67% from 52-week high of $76.51 — deep drawdown territory. Revenue growing +11%, comfortably above the S&P median. PEG 0.59 — paying under fair value for the growth rate. 18 sell-side analysts rate this a Hold with a mean 1-yr target of $29.78 (implying +18% upside).
Moat
Net margin 25% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 18% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 183% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Down 67% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 30x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
HNGEHinge Health, Inc.
Health Information Services · $89.98
Why now
Health Information Services · market cap $7.3b. 3% off the 52-week high of $93.13. Revenue growing +50% — in hypergrowth territory. PEG 0.38 — paying under fair value for the growth rate. 15 sell-side analysts rate this a Buy with a mean 1-yr target of $106.47 (implying +18% upside).
Moat
Net margin 15% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 32% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
P/S 10.1x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
DOCS leads HNGE by 12.2 points (84.2 to 72.0). A contrarian could still prefer HNGE for its stronger Rev (grade A). Note they play different roles — DOCS screens as growth, HNGE screens as value — so the model rewards different traits for each.
Our AI analyst is busy right now, so this verdict is drawn directly from the pillars, grades and DCF above.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

Where DOCS and HNGE diverge

On the headline score the gap is 12.2 points in favor of DOCS. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.

Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.